Press release
Total items：7 | Current page 1/1
Fucoidan Prevents M2 Macrophage Differentiation and HCT116 Tumor Progression in Mice NHRI
A Novel Imaging-guided High-Intensity Focused Ultrasound System for Treatment of Breast Tumors
A Culturally Adapted Treatment Program to Help Recovery from Methamphetamine Addiction in Taiwan
Reprogramming Inflammatory Tumor Microenvironment Enhances anti-PD-L1 Cancer Immunotherapy by Va
A Novel Tumor Suppressor Regulating Prostate Cancer Metastasis: ROR2 receptor April 16, 2021 Sc
US FDA approves Taiwan-developed anti-cancer drug-delivery system for phase I clinical study March
NHRI has established a novel application of MSNs, enhancing the utility and market development of lipase inhibitor-based anti-obesity drugs by reducing their side effects and elevating life quality